Coeliac Disease Sufferers – Are You Interested in The Clinical Trial
Yesterday I found this article in my inbox, from Food Processing.com. I thought that I would share it with you all as most of us are following restricted diets.
What’ll this do to the gluten-free market?
Tuesday, 27 March 2018
This will mean that if the trial is successful, those with an allergy to the protein strain in grain, will be able to consume them without suffering any adverse effects.
Interesting times really as those with a gluten allergy may have their problem abolished with a vaccine?
Are you Interested in the clinical trial?
Coeliac disease is a serious chronic medical condition. In which the ingestion of gluten, even in small amounts, leads to an immune response that causes damage to the small intestine.
Sufferers struggle with various gastrointestinal symptoms. If untreated, face potentially serious complications. Currently, the only way to manage the disease is through the strict avoidance of gluten in the diet.
USC’s Clinical Trials Centre Director Lucas Litewka said the investigational vaccine would be given to trial participants as an injection twice a week for seven weeks. He said the trial would be conducted alongside gastroenterologist Dr James Daveson at the Clinical Trial Centre on Sippy Downs Drive, Sippy Downs.
Dr Daveson said a gluten-free diet was exceptionally demanding for patients. Expensive and difficult to maintain as gluten was used extensively in modern food production. “There is a real unmet need for therapies other than the gluten-free diet for some people with coeliac disease”, he said.
This is a very exciting potential new therapy that has been undergoing clinical trials for several years now”.
Dr Daveson said the investigational vaccine might potentially restore gluten tolerance in coeliac disease sufferers.
Adults between the ages of 18 and 70 can take part in this trial. If they have medically diagnosed coeliac disease and have been following a strict gluten-free diet for 12 months or more. Those who meet the criteria and are enrolled in the study will be compensated for their time.
Patients interested in participating can go to www.joinourtrials.com or phone (07) 5456 3797.
Find original article here